Health Condition 1: null- Patients presenting with menorrhagia(PBAC score 100) and pelvic pain, pressure symptoms attributable to uterine fibroids.
Conditions
Interventions
Intervention1: Uterine artery embolisation: Endovascular catheter uterine artery embolisation will be done using particulate material like poly vinyl alcohol(PVA) to reduce the vascular supply and cau
Sponsors
Department of Radiodiagnosis
Eligibility
Inclusion criteria
Inclusion criteria: Menstruating women with symptomatic uterine fibroids who have completed their family Uterus size= 3 cm diameter in size
Exclusion criteria
Exclusion criteria: 1.Uterine size > 24 weeks on clinical examination. 2. Any single myoma size > 12 cm on ultrasonography. Patients can also be taken up for UAE post trial of GnRH agonists if the fibroid 3. size at presentation is more than 12 cm at initial presentation 4.Active pelvic infection or pregnancy 5.Suspected or known case of gynecological cancer/atypical endometrial hyperplasia. 6. Known case of uncontrolled coagulation disorder, renal insufficiency, severe contrast allergy 7. Large uterine polyp ( >2 cm), Submucosal fibroid (class 0 & 1 under myoma sub-classification system) 8. Large subserosal fibroids with narrow stalk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fibroid size as assessed by USG or MRI Uterine fibroid Quality of life assessment score Timepoint: 6 months after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Relief of symptoms like pain, pressure symptoms and menorrhagia Percentage necrosis of myoma on post embolization MRITimepoint: Relief of symptoms in 6 months Percentage necrosis on post embolisation MRI in 6 weeks | — |
Countries
India
Contacts
Public ContactProf Shivanand R Gamanagatti
All India Institute of Medical Sciences
Outcome results
None listed